Research location
Palermo
Italy
Advertisement
Research activity in Palermo
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 311 trials and 345 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Palermo
311 linked trials · page 2 of 7ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsNCT05671510 · 2023-06-28 · 1 site observation
ACTIVE_NOT_RECRUITING
A Dynamic Evaluation of Chronic Heart Failure Prognosis: the MECKI ScoreNCT06070519 · 2023-05-01 · 1 site observation
UNKNOWN
A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in ItalyNCT05759273 · 2023-04-24 · 1 site observation
COMPLETED
Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPDNCT05612035 · 2023-03-16 · 1 site observation
ACTIVE_NOT_RECRUITING
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)NCT05649748 · 2023-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)NCT05526755 · 2023-03-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)NCT05668988 · 2022-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study for Observing Severe Asthma in Patients Treated With TezepelumabNCT05677139 · 2022-12-13 · 1 site observation
COMPLETED
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)NCT05557942 · 2022-11-02 · 1 site observation
TERMINATED
Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseNCT05480046 · 2022-10-18 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily InjectionsNCT05462756 · 2022-08-11 · 1 site observation
COMPLETED
A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)NCT05282121 · 2022-06-28 · 1 site observation
TERMINATED
A Study to Test Whether Two Different Doses of Avenciguat Help People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)NCT05161481 · 2022-04-27 · 1 site observation
TERMINATED
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)NCT05243680 · 2022-03-01 · 1 site observation
COMPLETED
Study in Adult Patients With Moderate to Severe AsthmaNCT04886999 · 2022-02-24 · 1 site observation
COMPLETED
Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)NCT04959799 · 2022-01-02 · 1 site observation
COMPLETED
A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)NCT05036135 · 2021-12-02 · 1 site observation
TERMINATED
Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung CancerNCT04774380 · 2021-11-11 · 1 site observation
COMPLETED
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerNCT05117242 · 2021-10-27 · 1 site observation
TERMINATED
Retrospective Study of 2nd-line Therapies After CDK4/6i + Hormonal Therapy in HR+/HER2- Advanced Breast CancerNCT05173103 · 2021-09-24 · 1 site observation
COMPLETED
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)NCT04968912 · 2021-09-21 · 1 site observation
COMPLETED
Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)NCT05063786 · 2021-09-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Multidimensional Approach for COPD and High ComplexityNCT04986332 · 2021-09-01 · 1 site observation
UNKNOWN
Effects of Rehabilitation and Kinesio Taping to Prevent Axillary Web Syndrome After Breast Cancer SurgeryNCT06269523 · 2021-07-21 · 1 site observation
COMPLETED
Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)NCT04888585 · 2021-06-23 · 1 site observation
TERMINATED
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic InpatientsNCT05360537 · 2021-04-01 · 1 site observation
COMPLETED
Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple SclerosisNCT04930380 · 2021-04-01 · 1 site observation
UNKNOWN
Eribulin as a Second-line Treatment in Triple-negative Advanced Breast CancerNCT05302778 · 2021-03-22 · 2 site observations
UNKNOWN
Cognition and HRQoL in Adults With Highly-active RMS in Year 3 and 4 After Initial Mavenclad® Dose (CLARIFY MS Extension)NCT04776213 · 2021-02-23 · 1 site observation
COMPLETED
A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic PhenotypeNCT04718103 · 2021-02-04 · 1 site observation
COMPLETED
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic PhenotypeNCT04718389 · 2021-01-26 · 1 site observation
COMPLETED
A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell FunctionNCT04628481 · 2021-01-12 · 1 site observation
TERMINATED
A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.NCT04899271 · 2020-12-14 · 1 site observation
TERMINATED
A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeNCT04460885 · 2020-11-25 · 1 site observation
COMPLETED
Self-Management Of Asthma By Forced Oscillation TechniqueNCT04963140 · 2020-11-16 · 1 site observation
TERMINATED
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 2 site observations
COMPLETED
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and ImmunotherapyNCT04591431 · 2020-10-07 · 1 site observation
UNKNOWN
A Study of Pulmonary Arterial Hypertension Participants Treated With Macitentan or SelexipagNCT04567602 · 2020-10-06 · 1 site observation
COMPLETED
Effects of COVID-19 Pandemic on the Outcomes of Colorectal CancerNCT04712292 · 2020-09-08 · 1 site observation
UNKNOWN
Follow Up of acuTe Heart failUre: a pRospective Echocardiographic and Clinical Study (FUTURE)NCT05204238 · 2020-09-01 · 1 site observation
UNKNOWN
Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic SurgeryNCT04615091 · 2020-08-30 · 1 site observation
UNKNOWN
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)NCT04423302 · 2020-07-08 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 2)NCT04338061 · 2020-07-02 · 1 site observation
TERMINATED
A Study to Describe Routine Treatment Pathways in Participants With Major Depression and Active Suicidal Ideation With Intent in ItalyNCT04463108 · 2020-06-23 · 1 site observation
COMPLETED
COVID19-hematological Malignancies: the Italian Hematology AllianceNCT04352556 · 2020-04-07 · 1 site observation
UNKNOWN
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)NCT04227327 · 2020-01-07 · 2 site observations
TERMINATED
Prospective Effectiveness and Safety Study of Cladribine in Participants Who Change First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)NCT04934800 · 2019-12-10 · 1 site observation
COMPLETED
Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic PatientsNCT04181190 · 2019-10-11 · 1 site observation
COMPLETED
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)NCT03940703 · 2019-09-19 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.